Skip to content

Clinical trials

Recruiting Lymphoproliferative Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Status: Recruiting Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20092
20131
20152
20172
20181
20191
20203
20211
20231
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
UNC Lineberger Comprehensive Cancer Center2
AVM Biotechnology Inc1
Baylor College of Medicine1
Children's Oncology Group1
Curis, Inc.1
Dana-Farber Cancer Institute1
Emory University1
Jennifer Amengual1
Kelonia Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders22
Lymphoma8
Immune System Diseases6
Lymphoma, Non-Hodgkin6
Neoplasms6
Multiple Myeloma5
Hodgkin Disease4
Immunoproliferative Disorders4
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma, Follicular4

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.